Mizuho analyst Dan Dolev raised the firm’s price target on Genpact (G) to $51 from $48 and keeps a Neutral rating on the shares following the company’s recent investor day meeting, where management provided a medium-term financial framework as well as new key performance indicators to track the company’s progress. The firm was “encouraged” by the greater detail on the company’s go-forward AI strategy, although it remains at Neutral as the firm argues that “it is still early days.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on G:
- Genpact’s Strategic Growth and Technological Advancements Drive Buy Rating
- Genpact sees medium-term double-digit adjusted earnings growth
- Genpact price target raised to $55 from $53 at TD Cowen
- Genpact’s Strategic Transition: Balancing Growth Opportunities with Market Realities
- Genpact trading resumes